These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6100059)

  • 1. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
    Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
    Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection.
    Asano Y; Yazaki T; Miyata T; Nakayama H; Hirose S
    Biken J; 1975 Mar; 18(1):35-40. PubMed ID: 167708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
    Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
    Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella infection in a children's hospital: prevention by vaccine and an episode of airborne transmission.
    Tsujino G; Sako M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):129-32. PubMed ID: 6100050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of live varicella vaccine in children with acute leukemia and malignant lymphoma.
    Sato Y; Miyano T; Kawauchi K; Yokoyama M
    Biken J; 1984 Sep; 27(2-3):111-3. PubMed ID: 6100046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 14. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.
    Asano Y; Takahashi M
    Pediatrics; 1977 Dec; 60(6):810-4. PubMed ID: 202916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.